Article info

Download PDFPDF

GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory

Authors

  1. a 301-398-6833 durhamn{at}medimmune.com
  2. b HoloweckyjN{at}MedImmune.com
  3. c rmacgill{at}verizon.net
  4. d McGlincheyK{at}MedImmune.com
  5. e leowc{at}medimmune.com
  6. f robbinss{at}MedImmune.com
View Full Text

Citation

Durham NM, Holoweckyj N, MacGill RS, et al
GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory

Publication history

  • Received February 2, 2017
  • Accepted May 9, 2017
  • First published June 20, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.